Southpoint Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$186M |
| 2 |
C.H. Robinson
CHRW
|
+$176M |
| 3 |
Amazon
AMZN
|
+$170M |
| 4 |
ASML
ASML
|
+$122M |
| 5 |
Louisiana-Pacific
LPX
|
+$55.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
lululemon athletica
LULU
|
+$178M |
| 2 |
Humana
HUM
|
+$147M |
| 3 |
Flutter Entertainment
FLUT
|
+$114M |
| 4 |
Capital One
COF
|
+$109M |
| 5 |
Datadog
DDOG
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.98% |
| 2 | Technology | 17.01% |
| 3 | Financials | 16.64% |
| 4 | Industrials | 16.34% |
| 5 | Consumer Discretionary | 15.27% |
Similar funds
Southpoint Capital Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Southpoint Capital Advisors held 50 positions worth $3.81B, down 4% from $3.97B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Southpoint Capital Advisors withdrew a net $392M in Q3 2025, closing 9 positions and reducing 14 holdings. Its most notable exit was lululemon athletica, an estimated $178M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
Against the trend, Southpoint Capital Advisors opened a new position in Thermo Fisher Scientific worth $194M.
- Southpoint Capital Advisors's largest Q3 2025 buy was Thermo Fisher Scientific: 400,000 shares worth $194M.
- Southpoint Capital Advisors added most to Delta Air Lines in Q3 2025, an estimated $45.7M increase.
- Southpoint Capital Advisors's biggest Q3 2025 reduction was Capital One, cutting an estimated $109M.
- Southpoint Capital Advisors fully exited lululemon athletica in Q3 2025, selling an estimated $178M.
- Southpoint Capital Advisors's ten largest holdings make up 49% of its $3.81B portfolio in Q3 2025.
- Southpoint Capital Advisors opened 12 new positions and closed 9 in Q3 2025.
- Southpoint Capital Advisors's portfolio value fell 4% quarter-over-quarter to $3.81B.
Based on Southpoint Capital Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.